| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.097 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.27 | 0.1 |